Hydroxyzine Hydrochloride
- Product NDC
- 70518-2279
- Requested package NDC
- 70518-2279-1
- 11-digit product format
- 705182279
- Labeler code
- 70518
- Product ID
- 70518-2279_49f0ba74-62af-655f-e063-6294a90a9f99
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydroxyzine Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA088618
- Marketing category
- ANDA
- Marketing start
- 2019-08-24
- Substance
- HYDROXYZINE DIHYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 70518-2279 | 70518-2279-1 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A088618-001 | HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AB | RLD, RS | 1986-01-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A088618-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A088618-001 | HYDROXYZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AB | RLD, RS | 1986-01-10 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A088618-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | REMEDYREPACK INC. | ca67c061-c743-4ebb-a9d5-ece488060663 | 2026-07-22 | Warnings, Adverse reactions | 088618 ANDA088618 70518-2279-1 70518-2279 70518227901 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Cardinal Health 107, LLC | b4d274ce-d616-4835-80ce-76270524ed36 | 2026-07-20 | Warnings, Adverse reactions | 088618 ANDA088618 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | American Health Packaging | 47bda4fe-ddb7-4140-900a-970373cc7acc | 2026-06-23 | Warnings, Adverse reactions | 088618 ANDA088618 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | St. Mary's Medical Park Pharmacy | 1767a886-ec92-39fb-e063-6294a90a1249 | 2026-06-03 | Warnings, Adverse reactions | 088618 ANDA088618 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | REMEDYREPACK INC. | 6ad55cd1-a284-4c3d-aa90-653704afdb75 | 2026-01-30 | Warnings, Adverse reactions | 088618 ANDA088618 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Northwind Health Company, LLC | db0dce55-5984-7580-e053-2a95a90a3695 | 2026-01-01 | Warnings, Adverse reactions | 088618 ANDA088618 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 93d117dd-e2bf-4daa-abe3-d4fefed3313c | 2025-09-11 | Warnings, Adverse reactions | 088618 ANDA088618 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 3f90259a-a684-498f-8963-d02eaba2e9db | 2025-09-08 | Warnings, Adverse reactions | 088618 ANDA088618 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 2b05bd0e-af57-4e74-92f8-a4311330142f | 2025-08-18 | Warnings, Adverse reactions | 088618 ANDA088618 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | 80309ec1-e5d5-4454-b8ce-67d7e6805e44 | 2025-07-31 | Warnings, Adverse reactions | 088618 ANDA088618 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Proficient Rx LP | d79be126-39cd-4dbb-ad88-0e4c18109dda | 2024-05-01 | Warnings, Adverse reactions | 088618 ANDA088618 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Hydroxyzine Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| HYDROXYZINE HYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 76755771U3 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995258 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| ca67c061-c743-4ebb-a9d5-ece488060663 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 57311cfb-679a-da1a-b70c-8757f7fc431a | Product name | 4 | 20250516 |
| aa1826f4-97c1-4705-bdf0-3bc7d234e618 | Product name | 2 | 20190618 |
| 75cb12ee-8eb2-4f1a-a332-5743a5d0da41 | Product name | 1 | 20151110 |
| 3ca5f78b-43dc-30fe-8014-55b922af52b3 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-2279-0 | Hydroxyzine Hydrochloride | 30 in 1 BLISTER PACK | TABLET, FILM COATED | 30 | 16 | |
| 70518-2279-1 | Hydroxyzine Hydrochloride | 30 in 1 BLISTER PACK | TABLET, FILM COATED | 30 | 16 | |
| 70518-2279-2 | Hydroxyzine Hydrochloride | 30 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 30 | 16 | |
| 70518-2279-3 | Hydroxyzine Hydrochloride | 30 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 30 | 16 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-2279 | HYDROXYZINE HYDROCHLORIDE TABLET, FILM COATED [REMEDYREPACK INC.] | 13 | Current NDC, Legacy NDC, 4 package rows | 20250309_ca67c061-c743-4ebb-a9d5-ece488060663.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995258 | hydrOXYzine HCl 25 MG Oral Tablet | PSN | ca67c061-c743-4ebb-a9d5-ece488060663 | 16 |
| 995258 | hydroxyzine hydrochloride 25 MG Oral Tablet | SCD | ca67c061-c743-4ebb-a9d5-ece488060663 | 16 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70518-2279-1 | 70518227901 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2279-1) | 2021-05-10 | 0000-00-00 | No | No | Current |